switzerland

Sales & Marketing

Swiss train speeding across bridge against landscape background

A fast start to 2026 signals continued investor confidence i...

Key factors in Switzerland’s success that could make other European life sciences hubs more attractive to investors.

News

Novartis probed by Swiss authorities over 'unlawful' patent ...

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a "possible u

News

Novartis may have found a buyer for Sandoz; report

Just a few weeks after Novartis revealed it was considering a sale of its generics business Sandoz, there are reports that a potential buyer has already come forward.

News

Swiss socialists say government should buy Sandoz

Switzerland's Social Democratic Party has argued that the government should step in and acquire Novartis' generics unit Sandoz if the company decides to sell it, according to local press re

News

ObsEva files uterine fibroid drug in US, chasing AbbVie, Myo...

Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of

News

Chord gets $16m to challenge Alexion with oral NMOSD drug

Swiss biotech Chord Therapeutics has come out of stealth mode with a $16 million first-round financing that will be used to progress a repurposed drug for rare disease neuromyelitis optica

A fast start to 2026 signals continued investor confidence i...

Novartis probed by Swiss authorities over 'unlawful' patent ...

Novartis may have found a buyer for Sandoz; report

Swiss socialists say government should buy Sandoz

ObsEva files uterine fibroid drug in US, chasing AbbVie, Myo...

Chord gets $16m to challenge Alexion with oral NMOSD drug

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

switzerland

Editor's Picks